These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 34407723)

  • 21. ACE inhibitors-An effective treatment for hyaluronic acid soft tissue filler delayed inflammatory reaction following COVID-19 vaccination.
    Michon A
    J Cosmet Dermatol; 2022 Apr; 21(4):1369-1370. PubMed ID: 35113497
    [No Abstract]   [Full Text] [Related]  

  • 22. Comparative in vivo degradation of hyaluronic acid-based fillers following injection of hyaluronidase.
    Cavallini M; Pierce A; Nakab L
    J Cosmet Dermatol; 2024 Jan; 23(1):356-357. PubMed ID: 37461249
    [No Abstract]   [Full Text] [Related]  

  • 23. Delayed Inflammatory Reaction to VYC-25L Hyaluronic Acid Filler in a Patient Without a Reaction to VYC-20L.
    Burleigh A; Rivers JK; Diao D
    Dermatol Surg; 2021 May; 47(5):745-746. PubMed ID: 32826603
    [No Abstract]   [Full Text] [Related]  

  • 24. Granulomatous reaction to hyaluronic acid filler material in oral and perioral region: A case report and review of literature.
    Alcântara CEP; Noronha MS; Cunha JF; Flores IL; Mesquita RA
    J Cosmet Dermatol; 2018 Aug; 17(4):578-583. PubMed ID: 28718201
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Commentary on: Efficacy of Percutaneous Intraarterial Facial/Supratrochlear Arterial Hyaluronidase Injection for Treatment of Vascular Embolism Resulting From Hyaluronic Acid Filler Cosmetic Injection.
    DeLorenzi C
    Aesthet Surg J; 2022 May; 42(6):656-659. PubMed ID: 35442425
    [No Abstract]   [Full Text] [Related]  

  • 26. Retrobulbar Injection for Hyaluronic Acid Gel Filler-Induced Blindness: A Review of Efficacy and Technique.
    Surek CC; Said SA; Perry JD; Zins JE
    Aesthetic Plast Surg; 2019 Aug; 43(4):1034-1040. PubMed ID: 31065750
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early ultrasound for diagnosis and treatment of vascular adverse events with hyaluronic acid fillers.
    Schelke LW; Velthuis P; Kadouch J; Swift A
    J Am Acad Dermatol; 2023 Jan; 88(1):79-85. PubMed ID: 31325548
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cetuximab associated dermal filler reaction.
    Pathmanathan S; Dzienis M
    BMJ Case Rep; 2019 Aug; 12(8):. PubMed ID: 31451454
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Temporary hair loss after injection of hyaluronic acid filler.
    van den Elzen H; Schelke L; Velthuis P
    J Cosmet Dermatol; 2022 Feb; 21(2):625-626. PubMed ID: 34525251
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management strategies for vascular complications in hyaluronic acid filler injections: A case series analysis.
    Choi SY; Shin SH; Seok J; Yoo KH; Kim BJ
    J Cosmet Dermatol; 2023 Dec; 22(12):3261-3267. PubMed ID: 37694495
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hyaluronidase: What is your fear?
    Bravo BSF; Bianco S; Bastos JT; Carvalho RM
    J Cosmet Dermatol; 2021 Oct; 20(10):3169-3172. PubMed ID: 34242464
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fibrotic reaction to hyaluronic acid fillers in the face.
    Peros I; Haneke E
    J Cosmet Dermatol; 2024 Aug; 23(8):2543-2546. PubMed ID: 38890804
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Allergic reaction to hyaluronidase use after hyaluronic acid filler injection.
    Kim MS; Youn S; Na CH; Shin BS
    J Cosmet Laser Ther; 2015; 17(5):283-5. PubMed ID: 25588036
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Delayed Paleness After Hyaluronic Acid Filler Injection: A Warning Sign of Vascular Compromise.
    Hsien-Li Peng P; Peng JH
    Dermatol Surg; 2018 Apr; 44(4):590-592. PubMed ID: 28858919
    [No Abstract]   [Full Text] [Related]  

  • 35. Infraorbital mass long after dermal filler injection: A report of two cases.
    Arici C; Tosuner Z
    J Cosmet Dermatol; 2023 Apr; 22(4):1245-1248. PubMed ID: 36606376
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Causes and management of sight threatening complications of dermal filler injections: A review.
    Botha VE; Insull EA
    Clin Exp Ophthalmol; 2024 Apr; 52(3):365-373. PubMed ID: 38380782
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ophthalmic Artery Occlusion After Cosmetic Facial Filler Injections.
    Shi H; Liang LL; Cui ZH
    JAMA Ophthalmol; 2018 Jun; 136(6):e180764. PubMed ID: 29902317
    [No Abstract]   [Full Text] [Related]  

  • 38. Cerebral Angiographic Findings of Cosmetic Facial Filler-related Ophthalmic and Retinal Artery Occlusion.
    Kim YK; Jung C; Woo SJ; Park KH
    J Korean Med Sci; 2015 Dec; 30(12):1847-55. PubMed ID: 26713062
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Delayed allergic hypersensitivity to hyaluronidase during the treatment of granulomatous hyaluronic acid reactions.
    Wu L; Liu X; Jian X; Wu X; Xu N; Dou X; Yu B
    J Cosmet Dermatol; 2018 Dec; 17(6):991-995. PubMed ID: 29159865
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impurities in Hyaluronic Acid Dermal Fillers? A Narrative Review on Nonanimal Cross-Linked Fillers.
    Wollina U; Goldman A; Kocic H; Andjelkovic T; Bogdanovic D; Kokić IK
    Facial Plast Surg Aesthet Med; 2024; 26(2):190-194. PubMed ID: 38387011
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.